AZITRA Trademark

Trademark Overview

On Wednesday, June 2, 2021, a trademark application was filed for AZITRA with the United States Patent and Trademark Office. The USPTO has given the AZITRA trademark a serial number of 90749810. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Wednesday, April 9, 2025. This trademark is owned by Azitra Inc.. The AZITRA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of microbiome therapeutics for skin disease; scientific research in the field of microbiome therapies; research and development of therapies for skin disease; biotechnology research; scientific research and development; pharmaceutical research services; Scientific research in the field of genetic engineering; research and development of therapies for skin disease using genetic engineering; research and development of Live Biotherapeutic Products (LBP) for the treatment of skin disease; all of the foregoing excluding ocular, peri-ocular, sight and diabetes fields
azitra

General Information

Serial Number90749810
Word MarkAZITRA
Filing DateWednesday, June 2, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateWednesday, April 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized word "AZITRA" to the right of two interlocking hexagons.
Goods and ServicesResearch and development of microbiome therapeutics for skin disease; scientific research in the field of microbiome therapies; research and development of therapies for skin disease; biotechnology research; scientific research and development; pharmaceutical research services; Scientific research in the field of genetic engineering; research and development of therapies for skin disease using genetic engineering; research and development of Live Biotherapeutic Products (LBP) for the treatment of skin disease; all of the foregoing excluding ocular, peri-ocular, sight and diabetes fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code042
First Use Anywhere DateFriday, January 31, 2020
First Use In Commerce DateFriday, January 31, 2020

Trademark Owner History

Party NameAzitra Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBranford, CT 06405
Party NameAzitra Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBranford, CT 06405

Trademark Events

Event DateEvent Description
Saturday, June 5, 2021NEW APPLICATION ENTERED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 16, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, February 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 14, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 14, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, September 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 1 FILED
Tuesday, June 13, 2023SOU EXTENSION 1 GRANTED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 2 FILED
Tuesday, December 17, 2024USE AMENDMENT FILED
Tuesday, December 17, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 20, 2024SOU EXTENSION 3 FILED
Thursday, June 20, 2024SOU EXTENSION 3 GRANTED
Thursday, June 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 20, 2024SOU EXTENSION 4 FILED
Friday, December 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 9, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 9, 2025SOU EXTENSION 4 GRANTED
Thursday, April 10, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

azitra research development disease skin therapies scientific engineering ocular genetic microbiome